These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19347731)

  • 21. Symposia: behind the scenes.
    Walker C
    Nature; 2014 Jun; 510(7506):565-6. PubMed ID: 24971440
    [No Abstract]   [Full Text] [Related]  

  • 22. How to organize a conference that's open to everyone.
    Fleming N
    Nature; 2019 Jul; 571(7766):S46-S47. PubMed ID: 31341294
    [No Abstract]   [Full Text] [Related]  

  • 23. Senior scientists' legacy opportunity.
    Conn VS
    West J Nurs Res; 2005 Dec; 27(8):946-8. PubMed ID: 16275692
    [No Abstract]   [Full Text] [Related]  

  • 24. Scientists and societies. Horizons in molecular biology.
    Jauch R
    Nature; 2005 Feb; 433(7028):904. PubMed ID: 15729352
    [No Abstract]   [Full Text] [Related]  

  • 25. Complementing or expanding on existing areas of research expertise: The importance of attending and organising conferences in specific clinical areas.
    Fiona-Maree Gilmartin J; Gnjidic D
    Res Social Adm Pharm; 2017; 13(3):656-657. PubMed ID: 28185766
    [No Abstract]   [Full Text] [Related]  

  • 26. Conferences failing to protect LGBT+ researchers.
    Mallapaty S
    Nature; 2020 Aug; 584(7821):335. PubMed ID: 32778706
    [No Abstract]   [Full Text] [Related]  

  • 27. The value of presenting at scientific conferences: reflections by a couple of early career researchers.
    Ridde V; Mohindra KS
    J Epidemiol Community Health; 2009 Jan; 63(1):3. PubMed ID: 19088117
    [No Abstract]   [Full Text] [Related]  

  • 28. Planning ahead.
    Smaglik P
    Nature; 2004 Dec; 432(7020):1063. PubMed ID: 15616570
    [No Abstract]   [Full Text] [Related]  

  • 29. Herbicide critic dropped from pollution conference.
    Dalton R
    Nature; 2004 Nov; 432(7014):136. PubMed ID: 15538331
    [No Abstract]   [Full Text] [Related]  

  • 30. EPA not responsible for 'uninvitation' of a critic.
    Jones JJ
    Nature; 2004 Dec; 432(7019):799. PubMed ID: 15602520
    [No Abstract]   [Full Text] [Related]  

  • 31. 'Loving the minimal FOMO': First major physics conference to go virtual sees record attendance.
    Castelvecchi D
    Nature; 2020 Apr; 580(7805):574. PubMed ID: 32332910
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter from the editor.
    Cheson BD
    Clin Adv Hematol Oncol; 2012 Oct; 10(10):632. PubMed ID: 23187769
    [No Abstract]   [Full Text] [Related]  

  • 33. A clean, green science machine.
    Nature; 2015 Mar; 519(7543):261. PubMed ID: 25788057
    [No Abstract]   [Full Text] [Related]  

  • 34. Breaking down translation barriers: investigator's perspective.
    Staff NP; Runge BK; Windebank AJ
    Sci Transl Med; 2014 Sep; 6(252):252cm7. PubMed ID: 25186172
    [No Abstract]   [Full Text] [Related]  

  • 35. Developments in the treatment of lymphoproliferative disorders: rising to the new challenges of CLL therapy. A report of a symposium presented during the 48th American Society of Hematology Annual Meeting and Exposition, December 8, 2006, Orlando, Florida.
    Clin Adv Hematol Oncol; 2007 Mar; 5(3 Suppl 5):1-14; quiz 15-6. PubMed ID: 17519887
    [No Abstract]   [Full Text] [Related]  

  • 36. Venetoclax Yields Strong Responses in CLL.
    Cancer Discov; 2016 Feb; 6(2):113-4. PubMed ID: 26701089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to behave at a research meeting.
    Fitzpatrick JJ
    Appl Nurs Res; 1992 May; 5(2):57-8. PubMed ID: 1642485
    [No Abstract]   [Full Text] [Related]  

  • 38. THE INVESTIGATOR'S RESPONSIBILITY TO THE PATIENT.
    LASAGNA L
    J Chronic Dis; 1963 Sep; 16():955-9. PubMed ID: 14066516
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.
    Hess G; Herbrecht R; Romaguera J; Verhoef G; Crump M; Gisselbrecht C; Laurell A; Offner F; Strahs A; Berkenblit A; Hanushevsky O; Clancy J; Hewes B; Moore L; Coiffier B
    J Clin Oncol; 2009 Aug; 27(23):3822-9. PubMed ID: 19581539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highlights in the treatment of chronic lymphocytic leukemia from the 2013 meeting of the American Society of Hematology.
    Molica S
    Expert Rev Hematol; 2014 Apr; 7(2):187-90. PubMed ID: 24617332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.